奥拉西坦治疗轻中型脑梗死的临床效果观察  

Clinical Effect of Mild and Moderate Cerebral Infarction with Oxiracetam

作　　者：卜淑华[1] 汪学军[1] 何杏玲[1] 

机构地区：[1]广东医学院附属三水医院,广东佛山528100

出　　处：《中外医学研究》2014年第7期22-23,共2页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：目的:观察奥拉西坦治疗轻中型脑梗死的疗效,以供临床参考。方法:选择2010年8月-2012年7月笔者所在医院收治的115例轻中型脑梗死患者作为研究对象,随机分为A组和B组。所有患者均接受常规综合治疗,B组在此基础上给予奥拉西坦治疗。连续用药2周后,对比两组患者认知功能、日常生活活动能力恢复情况的差异性。结果:与治疗前比较,两组患者治疗后MMSE评分、Barthel指数均有所上升,其中B组上升幅度明显高于A组,差异有统计学意义(P<0.05)。结论:奥拉西坦在轻中型脑梗死的治疗中疗效具有一定的优越性,可明显改善患者记忆、智能障碍,提高生活质量,值得在今后的临床工作中推广应用。Objective：To observe the curative effect of oxiracetam in the treatment of mild and moderate cerebral infarction.Method：Choosing 115 cases from Aug 2010 to Jul 2012 in our hospital as research object,they were randomly divided into A group and B group.All patients received routine treatment,B group was treated with oxiracetam.After 2 weeks,comparing the cognitive function and activities of daily living of two groups.Result：Compared with before treatment,the MMSE score and Barthel index of two groups were increased.After treatment,B group was higher than A group,the difference was statistically significant（P〈0.05）.Conclusion：Oxiracetam has certain advantages in the treatment of mild and moderate cerebral infarction patients,can improve memory, mental retardation and the quality of life,is worthy of application in clinical work in the future.

关 键 词：奥拉西坦 轻中型脑梗死 认知功能 日常生活活动能力 

分 类 号：R743.33[医药卫生—神经病学与精神病学]